10/21 CVA Intervention Flashcards

1
Q

Recovery after stroke - Initial Phase

A

Decreased cerebral edema
Absorption of damaged tissue
Improved blood flow
Reperfusion of the ischemic penumbra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Recovery after stroke - Reparative Phase

A

Regeneration via collateral sprouting
Reorganization of neuropathways
Regression of peri-lesional inhibition
Intracortical disinhibition of the contralateral motor cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Keys to stroke rehab

A

Early mobilization

Prevention of learned non-use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recovery from stroke - Main points

A
Reperfusion of ischema
Axonal sprouting
Reorganization of motor cortex
Alterations in behavior
Prevention of learned non-use
Promote plasticity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stroke Recovery Timeline

A

Neurologic recovery generally takes place within 3 months

Further recovery may take place 6 months to one year later, but some motor function must be preserved in order for this to happen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

UE vs LE Recovery After Stroke

A

UE recovery vs LE recovery after stroke may differ
LE can achieve function with less motor control than UE due to task requirements
Partial recovery in LE can appear to be more recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stages of Stroke Recovery

A

Acute
< 1 month or < 8 weeks

Subacute
1-6 months

Chronic > 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stroke Prognosis - Sitting Balance

A

Sitting balance 2 weeks after stroke is predictive of walking ability after 6 months.

Initial sitting balance most correlated standing, walking, stair climbing at 6 months post-stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stroke Prognosis - Gait Speed & Endurance

A

Normative velocity values for independent community ambulation:
Distance - 332 meters (approximate 6MWT)
Velocity -1.2m/s = 2.68 mph

Household ambulation (0.4 m/s), limited
Limited community ambulation (0.4 to 0.8 m/s)
Full community ambulation (0.8 m/s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Stroke Prognosis - Fugl-Meyer

A
Fugl Meyer scores:
>80    mild
56-79 moderate
36-55 moderately severe
0-35   severe

Fugl-Meyer scores at 5 days post CVA were
predictive of 6 month motor performance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Stroke Prognosis - Barthel Index

A

Mild or moderate motor deficits 5 days and 30 days - 100% were independent in ADL after 6 months

Severe deficit 30 days - 56% were independent in ADLs after 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Stroke Prognosis - Orpington Prognostic Scale (OPS)

A

OPS at 2 weeks predictive of d/c if over 75 y.o.

5.2 req. LTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stroke Prognosis - Positive Indicators

A

Initial return of movement within the first 2 weeks
Active participation by patient
Specificity of and functional task oriented training
Acuity of stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Stroke Prognosis - Negative Indicators

A
Coma at outset
Poor cognition
Severe aphasia
No motor return within one month
Visual-perceptual-spatial disorders
Inability to sit unsupported
Incontinence 2 weeks s/p CVA
Depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stroke Treatment - Prevention

A
Falls
Injury
Fracture
Contracture
Joint subluxation
Skin breakdown
Learned non-use
Pneumonia
Deconditioning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stroke Treatment - Remediation

A
Muscle Activation
Force production
Balance 
Sensation
Functional mobility training
17
Q

Muscle Activation Tactics

A

Type of contraction
Position for task
Facilitation techniques
Constraint-Induced Movement Therapy (CIMT)
Neuromuscular electrical stimulation (NMES)

18
Q

Force Production Tactics

A
Repetitious exercises
Activities in kneeling and standing
Quick Stretch
Tapping
Weight bearing
19
Q

Sensation Tactics

A

Visual cues
mirror feedback
Proprioceptive input
Brushing

20
Q

Stroke Treatment - Compensation

A

Muscle Activation
Force Production
Balance
Functional Mobility

21
Q

Symmetry Training

A

Task specific reaching does not improve seated weight distribution or standing symmetry post-stroke.

Training awareness of body position can improve symmetry in sitting in the early phase of stroke rehabilitation for the short and long term.

22
Q

Aerobic Activity Recommendations, post-stroke

A

50-80% maximal heart rate
RPE 11-14 (6-20 scale)
3-7 days per week
20-60 minutes per session

23
Q

Strength Training Recommendations, post-stroke

A

1-3 sets of 10-15 reps
8-10 exercises of major muscle groups
2-3 days per week

24
Q

Body weight Supported Treadmill Training (BWSTT) Rationale

A

Intensive task-specific locomotor training
Repeated segmental sensory inputs
May facilitate cortical and subcortical reorganization
Allows an individual to integrate weight bearing, stepping and balance
Minimizes the delay that gait training can be initiated for individuals who are not able to support their full weight

25
Body weight Supported Treadmill Training (BWSTT) Limitations
Equipment needed Often requires 2 people to assist Differences between treadmill walking and over ground walking
26
BWSTT - Subacute Phase
Low initial ambulatory status - better than over ground Higher initial ambulatory status - not as good as over ground
27
Strength Training post-stroke, by level of function
Lower functioning patients: Task-Related Training Use more compensatory trunk motion to achieve improved reaching Higher functioning patients: Progressive Resistance Exercise More isolated control for reaching in the involved UE
28
Constraint Induced Movement Therapy (CIMT) – Subacute Phase
14 consecutive days of physical restraint on the less affected upper extremity Restraint is worn for 90% of waking hours 6 hours per day, 5 days per week of intensive training
29
Constraint Induced Movement Therapy (CIMT) Prerequisites
Higher functioning participants have at least: 20 degrees of wrist extension 10 degrees of active ext of each MP and IP joints of all digits Lower functioning participants have at least: 10 degrees of active wrist extension 10 degrees thumb ABDuction 10 of ext in at least 2 additional digits These movements repeated 3 times in one minut
30
Modified Constraint Induced Movement Therapy (CIMT)
1 hour of skilled PT/OT per day 3 days per week 10 weeks Less affected UE restrained 5 days per week for 5 hours
31
Functional Electrical Stimulation (FES)
Longer term use Used during functional activities Evidence for shoulder subluxation (prevention and compensation) Dorsiflexion assist during swing phase of gait (compensation) Increase motor unit recruitment Increase rate of motor unit firing
32
Electric Scooter Advantages
May dissemble or chair folds down May fit into trunk of car Beneficial for long distances in community access
33
Electric Scooter Disdvantages
“Captain’s Chair” Offers little postural support Large turning radius Difficult transfers
34
Functional Electrical Stimulation (FES) Evidence
Limited evidence may have some benefit when used in conjunction with traditional physical therapy (Faghri 1994, Faghri and Rodgers 1997, Chantraine 1999) Moderate evidence that does not prevent loss of shoulder function (Linn 1999) “FES in addition to standard therapy or no therapy is not more effective than conventional therapy or no therapy alone for improving functional independence in patients with acute stroke.” “EMG-triggered FES in combination with conventional therapy is more effective than conventional therapy alone for improving functional independence in patients with sub-acute stroke.”  “FES in addition to bilateral motor training or conventional therapy is more effective than bilateral training or conventional therapy alone for improving strength in patients with chronic stroke.” Not for improving for LE treatment in acute, subacute or chronic stages